Flag of the European Union EU Clinical Trials Register Help

Clinical trials for fluoxetine

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

  • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).


    The EU Clinical Trials Register currently displays   44341   clinical trials with a EudraCT protocol, of which   7370   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    Query did not match any clinical trials.
    These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006).
    Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records.
    1  2  Next»
    Study title: Fluoxetine In The Treatment Of Premenstrual Dysphoric Disorder (Pmdd) In Adolescents : An Open-Label Pilot Study
    Active substance: FLUOXETINE
    Study summary document link (including results): Fluoxetine - B1Y-MC-HCLF Synopsis.pdf
    View full study record
    Document reference: 28329
    Study title: Fluoxetine Major Depressive Disorder
    Active substance: FLUOXETINE
    Study summary document link (including results): Fluoxetine - B1Y-IT-M002 Summary.pdf
    View full study record
    Document reference: 28340
    Study title: Fluoxetine V Mianserin D.B. Depressed Patients
    Active substance: FLUOXETINE
    Study summary document link (including results): Fluoxetine - B1Y-IT-M003 Summary.pdf
    View full study record
    Document reference: 28341
    Study title: "Fluoxetine Versus Placebo in Adolescent Depressed Patients "
    Active substance: FLUOXETINE
    Study summary document link (including results): fluoxetine B1Y-MC-HCCJ Clinical Study Summary.pdf
    View full study record
    Document reference: 28334
    Study title: Fluoxetine Versus Placebo in Childhood/Adolescent Depression
    Active substance: FLUOXETINE
    Study summary document link (including results): fluoxetine B1Y-MC-HCJE Clinical Study Summary.pdf
    View full study record
    Document reference: 47358
    Study title: Fluoxetine Versus Placebo In Social Phobia
    Active substance: FLUOXETINE
    Study summary document link (including results): Fluoxetine - B1Y-MC-HCHP Synopsis.pdf
    View full study record
    Document reference: 28327
    Study title: A Double-Blind Placebo-Controlled Study of Fluoxetine and Clomipramine in the Treatment of Panic Disorder
    Active substance: FLUOXETINE
    Study summary document link (including results): Fluoxetine - B1Y-EW-HCHQ Synopsis.pdf
    View full study record
    Document reference: 28335
    Study title: Discontinuation Of Fluoxetine In Ocd
    Active substance: FLUOXETINE
    Study summary document link (including results): Fluoxetine - B1Y-SZ-IS38 Synopsis.pdf
    View full study record
    Document reference: 28331
    Study title: "Fluox20mg V Fluox40mg V Clomip75mg Out Pt. Maj. Depression
    Active substance: FLUOXETINE
    Study summary document link (including results):
    View full study record
    Document reference: 28339
    Study title: Fluoxetine hydrocloride with enteric cover
    Active substance: FLUOXETINE
    Study summary document link (including results):
    View full study record
    Document reference: 28342
    Study title: "Fluoxetine Vs Placebo In Obsessive Compulsive "
    Active substance: FLUOXETINE
    Study summary document link (including results):
    View full study record
    Document reference: 28337
    Study title: Fluoxetine Vs Placebo In Ocd Relapse Prevention
    Active substance: FLUOXETINE
    Study summary document link (including results):
    View full study record
    Document reference: 28328
    Study title: Fluoxetine Vs Placebo In Post Natal Depression
    Active substance: FLUOXETINE
    Study summary document link (including results):
    View full study record
    Document reference: 28326
    Study title: "Fluoxetine vs. Placebo in the Acute Treatment of Major Depressive Disorder in Children and Adolescents
    Active substance: FLUOXETINE
    Study summary document link (including results): fluoxetine B1Y-MC-X065 Clinical Study Synopsis.pdf
    View full study record
    Document reference: 28343
    Study title: Fluoxetine: In Depression And Ocd (Compassionate Use)
    Active substance: FLUOXETINE
    Study summary document link (including results):
    View full study record
    Document reference: 28332
    Study title: Fluoxetine/Placebo In Panic Disorder
    Active substance: FLUOXETINE
    Study summary document link (including results):
    View full study record
    Document reference: 28338
    Study title: Impact Of Fluoxetine On Growth In Children And Adolescents
    Active substance: FLUOXETINE
    Study summary document link (including results):
    View full study record
    Document reference: 28330
    Study title: Pharmacokinetic Assessment of Fluoxetine and Norfluoxetine in Preadolescent and Adolescent Patients
    Active substance: FLUOXETINE
    Study summary document link (including results): fluoxetine B1Y-MC-HCIU Clinical Study Summary.pdf
    View full study record
    Document reference: 47357
    Study title: "Prozac.Epidemiological Study In Obsessional Compulsive Disorder "
    Active substance: FLUOXETINE
    Study summary document link (including results):
    View full study record
    Document reference: 28336
    Study title: Tomoxetine + fluoxetine for Poor Metabolizer exposures
    Active substance: FLUOXETINE
    Study summary document link (including results): fluoxetine B4Z-MC-LYAQ Clinical Study Summary.pdf
    View full study record
    Document reference: 28333
    1  2  Next»
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu Jun 05 22:56:37 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA